NextCure, Inc.NXTCNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P13
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-19.25%
2024-20.24%
2023-9.23%
20225.53%
202120.67%
202077.35%
2019181.99%
201831.37%
20170.00%